ResearcherFirst Affiliated Hospital of Soochow UniversityNo recent work listed

Chen Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-0067-9271; OpenAlex author ID A5100374154. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2021: 1 paper

Papers 1

Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. Co-author DOI 10.21037/jgo-21-303 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yijun Wei · 1 shared paper, 2021 · strength 0.13
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303 ↗
Haoran Li · 1 shared paper, 2021 · strength 0.13
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303 ↗
Dongming Zhu · 1 shared paper, 2021 · strength 0.13
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303 ↗
Yuchen Tang · 1 shared paper, 2021 · strength 0.13
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303 ↗
Jian Zhou · 1 shared paper, 2021 · strength 0.13
- Paper Integrative analysis of TNFRSF6B as a potential therapeutic target for pancreatic cancer. DOI 10.21037/jgo-21-303 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.